Inducing Immunity. For Life.

About us

Technology

Pipeline

News

About us

Scientific Advisory Board

Management

Alon Moran, LLB, MBA, Chief Executive Officer
Alon Moran brings to Enlivex a wealth of industry experience in management and business development. Before joining the company, Mr. Moran was CEO of Biomas Ltd., a clinical phase company developing innovative, small molecule drugs. Prior to that, he served as VP Business Development for Inflamet, developer of an innovative inflammation evaluation device. Mr. Moran has also consulted for a variety of other life science ventures as well. He holds degrees in law and economics from the Hebrew University of Jerusalem, where he graduated with honors. He earned an MBA from Bar Ilan University.

Prof. Dror Mevorach, MD, Founder and Chief Scientific Officer
Professor Dror Mevorach is Head of Internal B Department at Hadassah Medical Center, Director of the Rheumatology Research Centre, former Acting Director at the Hadassah – Hebrew University Medical Center in Jerusalem, and Senior Lecturer in Medicine at the Hebrew University – Hadassah School of Medicine. Dr. Mevorach, a world leader in apoptosis research, is a member of several international medical and scientific societies. He has published almost 80 scientific papers in his field and is a frequent lecturer at international conferences around the world. Dr. Mevorach received his MD from the Technion in Israel.

Inna Reiner, PhD, R&D Director
Dr. Inna Reiner leads the pre-clinical activities of the company's R&D team, including drug characterization, cGMP and CMC development, and supervision of the in-vivo animal model research activities. An expert in apoptosis and cell immunology, Dr. Reiner received her PhD from the Hebrew University in Jerusalem, and conducted her doctoral research work under the guidance of Professor Dror Mevorach. Dr. Reiner is the author of several scientific papers on clearance of apoptotic cells.

| |